Immunogenicity, efficacy, effectiveness and overall impact of HPV vaccines

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Practically all genital infections with human papillomavirus (HPV) stem from sexual transmission following sexual debut, after which half of the young women are infected within 3 years (Collins et al. 2002; Winer et al. 2003). HPV transmission does not necessarily require mucosal contact but can also happen through contact of the skin and the genital mucosa (Moscicki et al. 2006). This is why both condom use and circumcision are protective against HPV transmission only partially (Winer et al. 2007; Wawer et al. 2011). It is noteworthy that HPV prevalence increases almost linearly with the increase of sexual partner numbers (Dillner et al. 1996; Koutsky 1997). Eventually, 70-80% of the sexually active population will acquire HPV infection. One third of young adult females and males are positive for HPV DNA, meaning they are able to transfer the virus (Auvinen et al. 2007; Kjaer et al. 2007; Giuliano et al. 2007).

Cite

CITATION STYLE

APA

Lehtinen, M., Nieminen, P., Apter, D., Namujju, P., Natunen, K., Rana, M., & Paavonen, J. (2012). Immunogenicity, efficacy, effectiveness and overall impact of HPV vaccines. In HPV and Cervical Cancer: Achievements in Prevention and Future Prospects (pp. 257–272). Springer New York. https://doi.org/10.1007/978-1-4614-1988-4_10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free